These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 14742757)

  • 1. Possible gatifloxacin-induced seizure.
    Quigley CA; Lederman JR
    Ann Pharmacother; 2004 Feb; 38(2):235-7. PubMed ID: 14742757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible gatifloxacin-induced hyperglycemia.
    Donaldson AR; Vandiver JR; Finch CK
    Ann Pharmacother; 2004 Apr; 38(4):602-5. PubMed ID: 14982977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ofloxacin-induced seizure.
    Walton GD; Hon JK; Mulpur TG
    Ann Pharmacother; 1997 Dec; 31(12):1475-7. PubMed ID: 9416384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gatifloxacin-induced hyperglycemia: a case report and summary of the current literature.
    Yip C; Lee AJ
    Clin Ther; 2006 Nov; 28(11):1857-66. PubMed ID: 17213006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilateral uveitis associated with fluoroquinolone therapy.
    Hinkle DM; Dacey MS; Mandelcorn E; Kalyani P; Mauro J; Bates JH; Soukasian SH; Holland GN; Foster CS; Fraunfelder FT; Davis JL; Fraunfelder FW
    Cutan Ocul Toxicol; 2012 Jun; 31(2):111-6. PubMed ID: 21981449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe hyperglycemia during renally adjusted gatifloxacin therapy.
    Blommel AL; Lutes RA
    Ann Pharmacother; 2005; 39(7-8):1349-52. PubMed ID: 15941822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alatrofloxacin-induced seizures during slow intravenous infusion.
    Melvani S; Speed BR
    Ann Pharmacother; 2000 Sep; 34(9):1017-9. PubMed ID: 10981247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoglycemia in inpatients after gatifloxacin or levofloxacin therapy: nested case-control study.
    Graumlich JF; Habis S; Avelino RR; Salverson SM; Gaddamanugu M; Jamma K; Aldag JC
    Pharmacotherapy; 2005 Oct; 25(10):1296-302. PubMed ID: 16185172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety concerns with fluoroquinolones.
    Mehlhorn AJ; Brown DA
    Ann Pharmacother; 2007 Nov; 41(11):1859-66. PubMed ID: 17911203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for hyperglycemia in hospitalized adults receiving gatifloxacin: a retrospective, nested case-controlled analysis.
    Mohr JF; Peymann PJ; Troxell E; Lodise TP; Ostrosky-Zeichner L
    Clin Ther; 2008 Jan; 30(1):152-7. PubMed ID: 18343251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outpatient gatifloxacin therapy and dysglycemia in older adults.
    Park-Wyllie LY; Juurlink DN; Kopp A; Shah BR; Stukel TA; Stumpo C; Dresser L; Low DE; Mamdani MM
    N Engl J Med; 2006 Mar; 354(13):1352-61. PubMed ID: 16510739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperglycemia and gatifloxacin: a case report and summary of current literature.
    Beste LA; Mersfelder TL
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):262-5. PubMed ID: 16503322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective, comparative evaluation of dysglycemias in hospitalized patients receiving gatifloxacin, levofloxacin, ciprofloxacin, or ceftriaxone.
    Mohr JF; McKinnon PS; Peymann PJ; Kenton I; Septimus E; Okhuysen PC
    Pharmacotherapy; 2005 Oct; 25(10):1303-9. PubMed ID: 16185173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seizures associated with fluoroquinolones.
    Kushner JM; Peckman HJ; Snyder CR
    Ann Pharmacother; 2001 Oct; 35(10):1194-8. PubMed ID: 11675843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generalized seizure and toxic epidermal necrolysis following levofloxacin exposure.
    Christie MJ; Wong K; Ting RH; Tam PY; Sikaneta TG
    Ann Pharmacother; 2005 May; 39(5):953-5. PubMed ID: 15827068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gatifloxacin 400 mg as a single shot or 200 mg once daily for 3 days is as effective as ciprofloxacin 250 mg twice daily for the treatment of patients with uncomplicated urinary tract infections.
    Naber KG; Allin DM; Clarysse L; Haworth DA; James IG; Raini C; Schneider H; Wall A; Weitz P; Hopkins G; Ankel-Fuchs D
    Int J Antimicrob Agents; 2004 Jun; 23(6):596-605. PubMed ID: 15194131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of gatifloxacin pharmacokinetics and pharmacodynamics in severely ill adults in a medical Intensive Care Unit.
    Fish DN
    Int J Antimicrob Agents; 2007 Jun; 29(6):715-23. PubMed ID: 17433631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advancing age and renal impairment as important predisposing factors of gatifloxacin-induced hyperglycemia in non-diabetes patients.
    Ovartlarnporn M; Jongjaroenprasert W
    J Med Assoc Thai; 2007 Mar; 90(3):569-73. PubMed ID: 17427537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of and risk factors for dysglycemia in patients receiving gatifloxacin and levofloxacin in an outpatient setting.
    LaPlante KL; Mersfelder TL; Ward KE; Quilliam BJ
    Pharmacotherapy; 2008 Jan; 28(1):82-9. PubMed ID: 18154478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myoclonus and generalized seizures associated with gatifloxacin treatment.
    Marinella MA
    Arch Intern Med; 2001 Oct; 161(18):2261-2. PubMed ID: 11575986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.